Financials

  • Market Capitalization 43.73 M
  • Employee 5
  • Founded 1979
  • CEO N/A
  • Website www.dyadic.com
  • Headquarter Delaware, United States
  • FIGI BBG000L276R1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.9
Relación precio/flujo de caja
7.21

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4303
MGX
Metagenomi Therapeutics, Inc. - Common Stock
1.30 USD-1.52%+0.78%+13.04%-9.72%48.94 M USD
4335
HYPD
Hyperion DeFi, Inc. - Common Stock
3.01 USD+1.69%+1.35%+1.35%-76.85%45.62 M USD
4373
PDSB
PDS Biotechnology Corporation - Common Stock
0.74 USD-1.33%-9.76%-25.25%-35.65%41.30 M USD
4378
APLM
Apollomics Inc. - Class A Ordinary Shares
19.19 USD+22.23%+0.47%+36.58%+229.16%42.14 M USD

Noticias